1. Home
  2. PRFX

PRFX

PainReform Ltd.

Logo PainReform Ltd.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 2:32pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Founded: 2007 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 1.6M IPO Year: 2020
Target Price: N/A AVG Volume (30 days): 140.1K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -7.14 EPS Growth: N/A
52 Week Low/High: $0.42 - $26.41 Next Earning Date: 05-13-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: